12-14 The presence of adverse gastrointestinal symptoms (nausea, vomiting, dyspepsia, abdominal distension) in patients taking GLP-1 agonists are predictive of increased residual gastric contents
Eli Lilly developed it as a triple receptor agonist, targeting GLP-1, GIP, and glucagon receptors
This pivotal clinical investigation reveals that semaglutide not only mitigates pivotal clinical endpoints but also substantially elevates health-related quality of life (QoL), embodying a transformative advance in the management of this high-risk patient cohort
Although most patients recover spontaneously from an acetaminophen overdose, the drug can cause life-threatening liver injury
They should be viewed as complementary lifestyle strategies rather than direct substitutes for pharmacotherapy when medication is clinically indicated
Starting at 2.5 mg , the schedule proceeds to 5 mg, 7.5 mg, 10 mg, 12.5 mg, and finally 15 mg